VMAlteration of bile acid metabolism in pseudo germ-free rats

Archives of Pharmacal Research

Volumn 35, Issue 11, 2012, Pages 1969-1977

  Bhowmik, Salil Kumar ^a,b   An, Ji Hye ^a,c   Lee, Soo Hyun ^a   Jung, Byung Hwa ^a,b  

^a Korea Institute of Science and Technology   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

Bile acids; Gas chromatography mass spectrometry; Liver toxicity; Oxysterol; Pseudo germ free rat

Indexed keywords

ALPHA MURICHOLIC ACID; BACITRACIN; BETA MURICHOLIC ACID; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; CYTOCHROME P450; NEOMYCIN; OXYSTEROL; OXYSTEROL 7ALPHA HYDROXYLASE; STREPTOMYCIN; UNCLASSIFIED DRUG; 7 ALPHA HYDROXYSTEROID DEHYDROGENASE; 7 ALPHA-HYDROXYSTEROID DEHYDROGENASE; ANTIINFECTIVE AGENT; CHOLIC ACID DERIVATIVE; HYDROXYSTEROID DEHYDROGENASE; MIXED FUNCTION OXIDASE; MURICHOLIC ACID; STEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CONTROLLED STUDY; GAS CHROMATOGRAPHY; INTESTINE FLORA; KIDNEY CONCENTRATING CAPACITY; LIVER TOXICITY; MALE; NONHUMAN; RAT; ANIMAL; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; MASS FRAGMENTOGRAPHY; METABOLISM; MICROBIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACITRACIN; BILE ACIDS AND SALTS; CHOLIC ACID; CHOLIC ACIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTROINTESTINAL TRACT; GERM-FREE LIFE; HYDROXYSTEROID DEHYDROGENASES; MALE; MIXED FUNCTION OXYGENASES; NEOMYCIN; RATS; RATS, SPRAGUE-DAWLEY; STEROLS; STREPTOMYCIN;

EID: 84874401174     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1114-7     Document Type: Article

References (34)

1. Bohnhoff, M. and Miller, C. P.; Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. J. Infect. Dis.; 111, 117-127 (1962).
2. Bourlioux, P.; Koletzko, B.; Guarner, F.; and Braesco, V.; The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium 'The Intelligent Intestine', held in Paris, June 14, 2002. Am. J. Clin. Nutr.; 78, 675-683 (2003).
3. Brendel, C.; Schoonjans, K.; Botrugno, O. A.; Treuter, E.; and Auwerx, J.; The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. Mol. Endocrinol.; 16, 2065-2076 (2002).
4. Carey, J. B.; Jr.; The serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease. J. Clin. Invest.; 37, 1494-1503 (1958).
5. Chawla, A.; Repa, J. J.; Evans, R. M.; and Mangelsdorf, D. J.; Nuclear receptors and lipid physiology: opening the Xfiles. Science, 294, 1866-1870 (2001).
6. Claus, S. P.; Tsang, T. M.; Wang, Y.; Cloarec, O.; Skordi, E.; Martin, F. P.; Rezzi, S.; Ross, A.; Kochhar, S.; Holmes, E.; and Nicholson, J. K.; Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol. Syst. Biol.; 4, 219 (2008).
7. Dunne, C.; Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm. Bowel. Dis.; 7, 136-145 (2001).
8. Forman, B. M.; Ruan, B.; Chen, J.; Schroepfer, G. J.; Jr.; and Evans, R. M.; The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl. Acad. Sci. U. S. A.; 94, 10588-10593 (1997).
9. Goodwin, B.; Jones, S. A.; Price, R. R.; Watson, M. A.; McKee, D. D.; Moore, L. B.; Galardi, C.; Wilson, J. G.; Lewis, M. C.; Roth, M. E.; Maloney, P. R.; Willson, T. M.; and Kliewer, S. A.; A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell, 6, 517-526 (2000).
10. Garde, A. H.; Hansen, A. M.; Kristiansen, J.; and Knudsen, L. E.; Comparison of uncertainties related to standardization of urine samples with volume and creatinine concentration. Ann. Occup. Hyg.; 48, 171-179 (2004).
11. Hofmann, A. F.; Bile acids, diarrhea, and antibiotics: data, speculation, and a unifying hypothesis. J. Infect. Dis.; 135, 126-132 (1977).
12. Hooper, L. V. and Gordon, J. I.; Commensal host-bacterial relationships in the gut. Science, 292, 1115-1118 (2001).
13. Houten, S. M.; Watanabe, M.; and Auwerx, J.; Endocrine functions of bile acids. EMBO J.; 25, 1419-1425 (2006).
14. Kumar, B. S.; Lee, Y. J.; Yi, H. J.; Chung, B. C.; and Jung, B. H.; Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Anal. Chim. Acta, 661, 47-59 (2010).
15. Kumar, B. S.; Chung, B. C.; Lee, Y. J.; Yi, H. J.; Lee, B. H.; and Jung, B. H.; GC/MS-based Simultaneous Quantitative Analytical Method for Urinary Oxysterols and Bile Acids in Rats. Anal. Biochem.; 408, 242-252 (2011).
16. Lee, D. S.; Kim, Y. S.; Ko, C. N.; Cho, K. H.; Bae, H. S.; Lee, K. S.; Kim, J. J.; Park, E. K.; and Kim, D. H.; Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res.; 25, 165-169 (2002).
17. Lu, T. T.; Makishima, M.; Repa, J. J.; Schoonjans, K.; Kerr, T. A.; Auwerx, J.; and Mangelsdorf, D. J.; Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell, 6, 507-515 (2000).
18. Makino, I.; Nakagawa, S.; and Mashimo, K.; Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases. Gastroenterology, 56, 1033-1039 (1969).
19. Martin, F. P.; Dumas, M. E.; Wang, Y.; Legido-Quigley, C.; Yap, I. K.; Tang, H.; Zirah, S.; Murphy, G. M.; Cloarec, O.; Lindon, J. C.; Sprenger, N.; Fay, L. B.; Kochhar, S.; van Bladeren, P.; Holmes, E.; and Nicholson, J. K.; A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol.; 3, 112 (2007).
20. Martin, F. P.; Sprenger, N.; Yap, I. K.; Wang, Y.; Bibiloni, R.; Rochat, F.; Rezzi, S.; Cherbut, C.; Kochhar, S.; Lindon, J. C.; Holmes, E.; and Nicholson, J. K.; Panorganismal gut microbiome-host metabolic crosstalk. J. Proteome Res.; 8, 2090-2105 (2009).
21. Masuda, N. and Oda, H.; 7 alpha-Dehydroxylation of bile acids by resting cells of an unidentified, gram-positive, nonsporeforming anaerobic bacterium. Appl. Environ. Microbiol.; 45, 456-462 (1983).
22. Miyata, M.; Takamatsu, Y.; Kuribayashi, H.; and Yamazoe, Y.; Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal FGF15 expression. J. Pharmacol. Exp. Ther.; 331, 1079-1085 (2009).
23. Nair, P. P.; Garcia-Lilis, C.; and Mendeloff, A. I.; Effect of lithocholic acid and antibiotics on tissue bile acids in the rat. J. Nutr.; 100, 698-704 (1970).
24. Nicholson, J. K.; Holmes, E.; and Wilson, I. D.; Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol.; 3, 431-438 (2005).
25. Russell, D. W.; The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem.; 72, 137-174 (2003).
26. Stellwag, E. J. and Hylemon, P. B.; 7alpha-Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J. Lipid Res.; 20, 325-333 (1979).
27. Thompson, M. B.; Blair, P. C.; Morris, R. W.; Neptun, D. A.; Deyo, D. F.; and Popp, J. A.; Validation and application of a liquid-chromatographic/ enzymatic assay for individual bile acids in the serum of rats. Clin. Chem.; 33, 1856-1862 (1987).
28. Uchida, K.; Okuno, I.; Takase, H.; Nomura, Y.; Kadowaki, M.; and Takeuchi, N.; Distribution of bile acids in rats. Lipids, 13, 42-48 (1978).
29. Van Der Schoor, S. R.; Reeds, P. J.; Stoll, B.; Henry, J. F.; Rosenberger, J. R.; Burrin, D. G.; and Van Goudoever, J. B.; The high metabolic cost of a functional gut. Gastroenterology, 123, 1931-1940 (2002).
30. Velagapudi, V. R.; Hezaveh, R.; Reigstad, C. S.; Gopalacharyulu, P.; Yetukuri, L.; Islam, S.; Felin, J.; Perkins, R.; Borén, J.; Oresic, M.; and Bäckhed, F.; The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res.; 51, 1101-1112 (2010).
31. Watanabe, M.; Houten, S. M.; Mataki, C.; Christoffolete, M. A.; Kim, B. W.; Sato, H.; Messaddeq, N.; Harney, J. W.; Ezaki, O.; Kodama, T.; Schoonjans, K.; Bianco, A. C.; and Auwerx, J.; Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature, 439, 484-489 (2006).
32. Xing, J.; Chen, X.; Sun, Y.; Luan, Y.; and Zhong, D.; Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J. Pharm. Pharmacol.; 57, 743-750 (2005).
33. Xu, M.; Guo, H.; Han, J.; Sun, S. F.; Liu, A. H.; Wang, B. R.; Ma, X. C.; Liu, P.; Qiao, X.; Zhang, Z. C.; and Guo, D. A.; Structural characterization of metabolites of salvianolic acid B from Salvia miltiorrhiza in normal and antibiotictreated rats by liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.; 858, 184-198 (2007).
34. Yap, I. K.; Li, J. V.; Saric, J.; Martin, F. P.; Davies, H.; Wang, Y.; Wilson, I. D.; Nicholson, J. K.; Utzinger, J.; Marchesi, J. R.; and Holmes, E.; Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J. Proteome Res.; 7, 3718-3728 (2008).